Coming up with a drug for Alzheimer’s is devilishly hard

There have been more than 400 failed clinical trials since the last approved Alzheimer’s treatment.

You must sign in or register to continue reading content.

More in Nation-World

Congress lurches toward government shutdown deadline

The thorniest issue seemed to be immigration policy, according to aides familiar with the talks.

Breaking up with Facebook? It’s harder than it looks

There’s just one problem: There isn’t much of anywhere else to go.

He didn’t like the beer, so he filed a class-action lawsuit

The claim against Pabst Brewing Co. alleges false advertising in the sales of its Olympia products.

Teen shoots girl in Maryland school, dies in confrontation

Sheriff: A prior relationship may have existed between the shooter and the female victim.

New blast sends bombing investigators to Texas FedEx center

Hours after the explosion, a bomb squad was sent to a FedEx in Austin to check a suspicious package.

Trump congratulates Putin on his reelection

Some world leaders hesitated, since Putin’s most prominent opponent was barred from the ballot.

Key design change stymied Florida bridge cost, schedule

It’s unclear if the change affected the collapse, but some worried delays could jeopardize funding.

Brazil mourns the murder of a rare hero

When she died in a hail of bullets — an apparent ambush — even crime-calloused Brazilians were shocked.

UK seeking warrant to access Cambridge Analytica servers

The company allegedly used data mined from Facebook to help Donald Trump win the 2016 election.

Most Read